SEARCH

SEARCH BY CITATION

References

  • 1
    Mosher DF. Plasma fibronectin concentration: a risk factor for arterial thrombosis? Arterioscler Thromb Vasc Biol 2006; 26: 11935.
  • 2
    Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108: 231722.
  • 3
    Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599610.
  • 4
    Cho J, Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 2006; 4: 14619.
  • 5
    Orem C, Durmus I, Kilinc K, Baykan M, Gokce M, Orem A, Topbas M. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Coron Artery Dis 2003; 14: 21924.
  • 6
    Ekmekci H, Ekmekci OB, Sonmez H, Ozturk Z, Domanic N, Kokoglu E. Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: impacts on thrombosis and thrombolysis. Clin Appl Thromb Hemost 2005; 11: 6370.
  • 7
    Song KS, Kim HK, Shim W, Jee SH. Plasma fibronectin levels in ischemic heart disease. Atherosclerosis 2001; 154: 44953.
  • 8
    Ulutin T, Sonmez H, Ucisik N, Suer S, Bayram C, Kokoglu E, Sultuybek G. The molecular markers of hemostatic activation on coronary artery disease. Thromb Res 1997; 88: 32932.
  • 9
    Zhang Y, Zhou X, Krepinsky JC, Wang C, Segbo J, Zheng F. Association study between fibronectin and coronary heart disease. Clin Chem Lab Med 2006; 44: 3742.
  • 10
    Thompson C, Blumenstock FA, Saba TM, Feustel PJ, Kaplan JE, Fortune JB, Hough L, Gray V. Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest 1989; 84: 122635.